{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-000270","form_type":"8-K","ticker":"ACHC","cik":"0001520697","company_name":"Acadia Healthcare Company, Inc.","filed_at":"2022-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.837980+00:00","generated_at":"2026-06-27T03:35:26.069538+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Acadia Healthcare Q4 revenue $593.5M, adjusted EPS $0.81; guides 2022 rev $2.55-2.60B","bullets":["Q4 revenue $593.5M, same facility +10.7%; adjusted EBITDA $156.1M.","Net income $70.3M ($0.77 diluted); adjusted EPS $0.81 ($0.67 ex-PRF).","Acquired CenterPointe Behavioral Health for $139M cash on Dec 31, 2021.","2022 guidance: rev $2.55-2.60B, adj. EBITDA $575-610M, adj. EPS $2.85-3.15.","Opened five new CTCs in Q4; plans 6-10 in 2022; announced three new JV partnerships."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-000270","json":"https://secwatch.observer/filing/0001157523-22-000270.json","markdown":"https://secwatch.observer/filing/0001157523-22-000270.md","text":"https://secwatch.observer/filing/0001157523-22-000270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1520697/000115752322000270/0001157523-22-000270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1520697/000115752322000270/a52586717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T03:35:26.069538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}